Sign in

CIK 0001124105

  • Accelerated filer
  • Smaller reporting company

GYRE THERAPEUTICS, INC.

Sign in to watch
Ticker
GYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562020050
Phone
+1 858-284-0115
Business address
12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
Former names
CATALYST BIOSCIENCES, INC., TARGACEPT INC
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Other disposition 10% owner disposed of 5,371,304 shares (other)
  6. 4 Returned to the company SVP Finance; Interim CFO & PAO returned 6.5 shares (to the company)
  7. 4 Returned to the company President & CEO returned 34.17 shares (to the company)
  8. 4 Returned to the company Director returned 28.23 shares (to the company)
  9. 4 Returned to the company 10% owner returned 6,266.52 shares (to the company)
  10. 4 Returned to the company Director returned 48.79 shares (to the company)
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market buy President & CEO bought 3,250 shares at $0.47 ($1,528)
  15. 4 Open-market buy SVP Finance; Interim CFO & PAO bought 3,250 shares at $0.47 ($1,528)
  16. 4 Open-market buy Chief Scientific Officer bought 3,250 shares at $0.47 ($1,528)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market buy President & CEO bought 3,250 shares at $0.46 ($1,495)
  20. 4 Open-market buy SVP Finance; Interim CFO & PAO bought 3,250 shares at $0.46 ($1,495)

Page 7 of 37 · 739 filings